Eucrates Biomedical Acquisition Corp.’s $100 Million Initial Public Offering

Proskauer represented Eucrates Biomedical Acquisition Corp. in the transaction. Eucrates Biomedical Acquisition Corp. (the “Company”), a special purpose acquisition company formed for the purpose of effecting…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here